✦ LIBER ✦

Development of oil cysts after subcutaneous injection of interferon-α and interleukin-2

✍ Scribed by E. Von Stebut; W. Bräuninger

Book ID: 108668997
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 687 KB
Volume: 155
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2006.07445.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ambulatory treatment of metastatic melan

Ambulatory treatment of metastatic melanoma associating subcutaneous dacarbazine, interferon α and interleukin-2

✍ B. Dréno; D. Cupissol; P. Joly; B. Sassolas; T. Bonneterre; J.M. Tourani 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 451 KB

Infectious complications of subcutaneous

Infectious complications of subcutaneous interleukin-2 and interferon-alpha

✍ Jones, A.L.; O'Brien, M.E.R.; Moore, J.; Cropley, I.; Lorentzos, A.; Jameson, B. 📂 Article 📅 1992 🏛 The Lancet 🌐 English ⚖ 469 KB

Immunotherapy of advanced renal cell can

Immunotherapy of advanced renal cell cancer using subcutaneous recombinant interleukin-2 and interferon-α

✍ H. Kirchner; W. Riese; E. Allhoff; H. Poliwoda; J. Atzpodien 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 450 KB

The combined administration of subcutaneous recombinant human interleukin-2 (rIL-2) and interferon-a (rIFN-~) was studied in a phase II trial on patients with advanced progressive renal cell cancer. Safety, tolerance and clinical response rate of this outpatient treatment protocol were assessed in 2

Treatment of advanced renal cell cancer

Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous α-interferon

✍ Besana, C.; Borri, A.; Bucci, E.; Citterio, G.; Di Lucca, G.; Fortis, C.; Matteu 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 904 KB

A phase II study of interferon α and low

A phase II study of interferon α and low-dose subcutaneous interleukin-2 in advanced renal cell carcinoma

✍ A. Piga; Paolo Giordani; Agata Quattrone; Marco Giulioni; Giorgio De Signoribus; 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 72 KB

A phase I study of subcutaneous recombin

A phase I study of subcutaneous recombinant interleukin-2 and interferon alfa-2a

✍ Mark J. Ratain; Edwin R. Priest; Linda Janisch; Nicholas J. Vogelzang 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB 👁 2 views

Background. Both recombinant in1 erferon alfa and interleukin-2 (IL-2) have been shown to lave some activity as single agents in metastatic renal cj !I1 cancer (RCC), although their activity is minimal in mo -e common solid tumors. Recent preclinical studies hav ? suggested that the combination of t